Antithrombotic therapy and survival in cancer patients.

  • Ajay K. Kakkar
  • Published 2009 in Best practice & research. Clinical haematology

Abstract

Venous thromboembolism is a common complication in patients with malignant disease. The development of symptomatic thromboembolism is associated with a poor prognosis for patients with cancer. Retrospective analysis of studies comparing unfractionated heparin with low-molecular-weight heparin (LMWH) for the initial treatment of deep vein thrombosis… (More)
DOI: 10.1016/j.beha.2009.01.004

Topics

Cite this paper

@article{Kakkar2009AntithromboticTA, title={Antithrombotic therapy and survival in cancer patients.}, author={Ajay K. Kakkar}, journal={Best practice & research. Clinical haematology}, year={2009}, volume={22 1}, pages={147-51} }